Xgene Pharmaceutical: Funding, Investors & Team (Sep 2026)
Xgene Pharmaceutical is a pharmaceutical company.
Xgene Pharmaceutical has raised $36.9M across 1 funding round on record, the most recent a Series D of $36.9M announced in Jul 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
Xgene Pharmaceutical Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Xgene Pharmaceutical Funding Rounds
Xgene Pharmaceutical Investors
15 investors are recorded in total; the 5 named above are those the record identifies.
Xgene Pharmaceutical Founders and Leadership Team
Contact details for the Xgene Pharmaceutical team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Xgene Pharmaceutical Funding in Context
Xgene Pharmaceutical's latest round of $36.9M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xgene Pharmaceutical in Biotechnology and Shanghai
Companies Similar to Xgene Pharmaceutical
Jinjing Keji manufactures cathode fluorescence system instruments.
Developer of electric outboards, batteries, and control systems for smart and sustainable water mobility.
Hello TransTech (formerly HelloBike) develops smart-sharing bikes for short distance travelers in China.
Chuangcai Advanced Education is a high-tech company that specializes in artificial intelligence and…
Anew Labs is an AI drug discovery company that combines generative models with experimental science.
Yincheng Intelligent focuses on the research, application, innovation, and development of new productivity…
Simitech manufactures advanced MEMS pressure sensors for defense and aerospace.
Senmaru is a wafer-level passive device integrated device manufacturer (IDM).
HiDream.ai develops artificial intelligence models for text-to-image generation and image editing.
Yige Cloud is a zero-trust enterprise network security solution provider.
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Yigen Technology,specializes in providing digital intellig ence solutions for the new energy sector
Xgene Pharmaceutical Funding FAQs
What does Xgene Pharmaceutical do?
Xgene Pharmaceutical is a pharmaceutical company.
How much funding has Xgene Pharmaceutical raised?
Xgene Pharmaceutical has raised $36.9M across 1 round on record. The most recent is a Series D of $36.9M announced in Jul 2026.
When did Xgene Pharmaceutical last raise funding?
Xgene Pharmaceutical's most recent funding round on record is a Series D of $36.9M, announced in Jul 2026.
Who has invested in Xgene Pharmaceutical?
Investors on record for Xgene Pharmaceutical include Real Capital Global, Jiaxing Yuanfan, CITIC Securities, GSR United Capital, Taiwania Capital Management Corporation. FundedIQ records 15 investors in total.
Who founded Xgene Pharmaceutical?
FundedIQ lists Feng Xu (Co-founder) at Xgene Pharmaceutical.
Where is Xgene Pharmaceutical headquartered?
Xgene Pharmaceutical is based in Shanghai, China.
How many employees does Xgene Pharmaceutical have?
Xgene Pharmaceutical is in the 11-50 employee band.
When was Xgene Pharmaceutical founded?
Xgene Pharmaceutical was founded in 2016.
About FundedIQ's Xgene Pharmaceutical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xgene Pharmaceutical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.